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After transplantation, glomerular volumes increases and
large glomerular volume at 4 months is associated with
better renal function. The aim is to characterize glomerular
adaptation after the fourth month in two serial protocol
biopsies and its relationship with subclinical rejection and
chronic allograft nephropathy (CAN). Mean glomerular
volume (Vg) was estimated according to the Weibel and
Gomez method in a 4-month and 1-year serial protocol
biopsies in 61 stable grafts. Glomerular enlargement (dVg)
was calculated as the Vg difference between both biopsies.
Banff schema was used to evaluate renal biopsies. Vg
increased from 4.472.4 to 5.772.6 106 lm3 (Po0.001).
Mean dVg was 1.0 106 lm3. Patients with dVgo1 were
considered as patients with impaired glomerular
enlargement (n¼ 29). Impaired glomerular enlargement was
associated with increased acute index score in the 4-month
(1.8371.56 vs 1.0671.48; Po0.05) and 1-year protocol
biopsies (1.5271.59 vs 0.6271.07; Po0.05). Impaired
glomerular enlargement was also associated with increased
progression of chronic lesions between the 4-month and
1-year biopsy in the glomerular (0.1770.38 vs 0.5570.63;
Po0.01), tubular (0.3870.56 vs 0.8370.85; Po0.01), and
interstitial compartment (0.4170.57 vs 0.9070.86; Po0.01).
The proportion of sclerotic glomeruli between both biopsies
increased in patients with impaired glomerular enlargement
(1.573.9 to 5.3710.1, Po0.05) while it did not modify in
patients with glomerular enlargement (2.177.3 vs 2.674.5;
P¼NS). During the first year, glomeruli enlarge but this
adaptation mechanism is impaired in patients with
subclinical rejection. Moreover, impaired glomerular
enlargement is associated with progression of CAN.
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There is a large variability in glomerular number in subjects
without known renal disease, ranging between 0.2 and
1.8 106. Autopsy studies have shown that there is an inverse
relationship between glomerular number and glomerular
volume.1,2 Low glomerular number and large glomerular
volume (Vg) are associated with hypertension, glomerulo-
sclerosis, and progressive renal failure.3,4 Since estimation of
glomerular number in vivo requires a complex approach,5,6 it
has been proposed that Vg may be considered a surrogate
parameter of glomerular number.7 Moreover, in renal
transplantation, large baseline glomerular size in donor
biopsies is associated with poor outcome.8,9
Vg increases during childhood to adapt to an increasing
metabolic demand, remains stable in young adults, and
further increases during aging in association with progressive
nephron loss in order to adapt renal function to a decreasing
nephron number.1,10,11 Vg also increases after nephrectomy as
an adaptation mechanism to nephron loss, but the capacity
of glomeruli to enlarge after nephrectomy is decreased in
older subjects.12,13
The evolution of Vg after renal transplantation has been
poorly characterized. Indication biopsies performed in
deteriorating kidneys showed an association between large
glomerular size and glomerulosclerosis.14 Recently, protocol
biopsies have been also used to study glomerular
adaptation early after transplantation in stable grafts. In a
study of serial preimplantation and 4-month protocol
biopsies, Vg increased by 20% and Vg at 4 months correlated
with creatinine clearance, suggesting that glomerular
enlargement after transplantation is a necessary condition
to achieve a better renal function.15 In this study, glomerular
enlargement was reduced in patients receiving kidneys
with large baseline Vg and in patients developing chronic
allograft nephropathy (CAN) at 4 months. These data point
out that both, donor and recipient factors, influence renal
adaptation after transplantation. However, glomerular adap-
tation after the fourth month in serial protocol biopsies has
not been explored. Thus, the aim of the present study is to
characterize glomerular adaptation between 4-month and
1-year evaluated by means of serial protocol renal allograft
biopsies and its relationship with subclinical rejection
and CAN.
http://www.kidney-international.org o r i g i n a l a r t i c l e
& 2006 International Society of Nephrology
Received 9 February 2006; revised 21 March 2006; accepted 18 April
2006; published online 21 June 2006
Correspondence: D Sero´n, Nephrology Department, Hospital Universitari
Bellvitge, C/Feixa Llarga s/n, 08907 L’Hospitalet, Barcelona. Spain.
E-mail: 17664dsm@comb.es
Kidney International (2006) 70, 557–561 557
RESULTS
Patients
During the study period, 61 cases with sufficient tissue in the
4-month and 1-year biopsy were available. Demographic
characteristics of patients are summarized in Table 1. Fifty-
two patients received a cyclosporine and prednisone-based
immunosuppression. This treatment was associated with
either monoclonal or polyclonal antilymphocyte induction
therapy (n¼ 18), azathioprine (n¼ 9), mycophenolate mo-
fetil (n¼ 14), or sirolimus (n¼ 1). Tacrolimus, mycopheno-
late mofetil, and prednisone-based immunosuppression was
employed in five cases. The remaining four cases received an
anticalcineurin-free immunosuppression with antilympho-
cyte therapy, mycophenolate mofetil, and prednisone.
Evolution of histological lesions
According to the Banff criteria, 4-month protocol biopsies
were diagnosed as normal (n¼ 25), borderline changes
(n¼ 13), acute rejection (n¼ 2), CAN (n¼ 9), CAN
associated with borderline changes (n¼ 7), and CAN
associated with acute rejection (n¼ 5). Histological diagnoses
in the 1-year protocol biopsies were normal (n¼ 23),
borderline changes (n¼ 2), CAN (n¼ 25), CAN associated
with borderline changes (n¼ 9), and CAN associated with
acute rejection (n¼ 2) (Po0.01). The proportion of
subclinical rejection decreased between both biopsies (44 vs
21%; Po0.01) while the proportion of CAN increased (34 vs
59%; P¼ 0.01). Acute and chronic Banff scores in each
biopsy are summarized in Table 2. We observed a significant
increase of mean glomerular volume as well as the
proportion of sclerotic glomeruli between both biopsies
while the tuft corpuscle ratio remained stable (Table 2). In
Figure 1, an example of glomerular enlargement between
both biopsies is shown.
Despite the progression of chronic renal damage, serum
creatinine, creatinine clearance, proteinuria, and mean
arterial pressure remained stable between the 4-month and
1-year protocol biopsy (Table 3).
Glomerular enlargement and histological lesions
Patients were classified into two groups according to the
mean value of dVg to evaluate the possible association
between glomerular enlargement and Banff scores. Mean dVg
was 1.0 106 mm3 and accordingly, patients with
dVgX1.0 106 mm3 were classified as patients with signifi-
cant glomerular enlargement (n¼ 32). In patients with
impaired glomerular enlargement, acute index was higher
than in patients with glomerular enlargement in the 4-month
biopsy (1.8371.56 vs 1.0671.48, Po0.05) and in the 1-year
biopsy (1.5271.59 vs 0.6271.07, Po0.05). Furthermore, in
patients without glomerular enlargement, the severity of
inflammation persisted while the severity of chronic lesions
increased in the glomerular, interstitial, and tubular com-
partments (Figure 2). Finally, in patients with glomerular
enlargement, there was a decrease in the degree of tubulitis
and an increase in the degree of tubular atrophy (Figure 2).
Table 1 | Demographic characteristics of patients
Variable Mean7s.d. Range
Donor age 36716 (14–72)
Donor gender (male/female) 41/20 —
Patient age (years) 45712 (20–68)
Patient gender (male/female) 38/23 —
Body mass index (kg/m2) 2373 (18–37)
Body surface area (m2) 1.770.1 (1.3–2.1)
Panel reactive antibodies (%) 6.5718 (0–93)
DR mismatches 0.670.6 (0–2)
Cold ischemia time (h) 21.574.9 (10–37)
Hepatitis C virus (positive/negative) 8/53 —
Delayed graft function (no/yes) 55/6 —
Acute rejection (no/yes) 49/12 —
s.d., standard deviation.
Table 2 | Acute and chronic Banff scores and mean glomerular
volume in protocol biopsies
Variable 4-month biopsy 1-year biopsy P
Glomerular sections 1476 1274 NS
Glomerulosclerosis (%) 1.875.9 3.977.8 o0.05
g-score 0.2170.58 0.2170.58 NS
i-score 0.6370.65 0.5270.69 NS
t-score 0.5570.71 0.2970.52 o0.05
v-score 0.0270.12 0.0270.12 NS
ah-score 0.2070.44 0.3170.64 NS
Acute index 1.4371.55 1.0471.41 o0.05
cg-score 0.1370.34 0.3170.53 o0.01
ci-score 0.3870.52 0.7270.71 o0.01
ct-score 0.3670.55 0.7470.70 o0.01
cv-score 0.1070.40 0.2370.59 NS
mm-score 0.3170.50 0.5470.62 o0.05
Chronic index 0.9771.37 2.0072.01 o0.01
Vtuft ( 106mm3) 4.472.4 5.772.6 o0.01
Vcorpuscle ( 106mm3) 5.772.6 7.372.9 o0.01
Vtuft/Vcorpuscle 0.7770.14 0.7770.13 NS
NS, not significant.
a b
c d
Figure 1 | Glomerular profiles in protocol biopsies. Glomerular
profiles in the 4-month and 1-year protocol biopsies in a renal
transplant (a, b) with significant glomerular enlargement and
(c, d) without glomerular enlargement. Hematoxylin–eosin stain,
 200.
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The percentage of glomerulosclerosis remained stable in
patients with glomerular enlargement, but significantly
increased in patients without glomerular enlargement
(Figure 3).
Vg in the 4-month protocol biopsy was associated with
dVg (R¼0.41, P¼ 0.001). Stepwise regression analysis
showed that Vg and acute index in the 4-month protocol
biopsy were independent predictors of dVg (R¼ 0.47,
Po0.001).
Glomerular enlargement and clinical variables
Only two clinical variables were associated with glomerular
enlargement. Recipients with glomerular enlargement were
older (49711 vs 41713 years, Po0.01) and had a higher
body mass index (2474 vs 2273 kg/m2, Po0.05) than
recipients without glomerular enlargement. Finally, stepwise
regression analysis taking into consideration histological and
clinical variables only considered Vg and acute index score in
the 4-month protocol biopsy as independent predictors of
dVg (R¼ 0.47, Po0.001).
DISCUSSION
In the present study, we observed that glomeruli enlarge
between the 4-month and 1-year by approximately 20%. In a
previous study, evaluating glomerular enlargement in a
donor and a 4-month protocol biopsy, we have already
observed that glomeruli enlarge during this period of time
also by approximately 20%.15 Taken together, these data
suggest that glomerular enlargement follows an exponential
pattern at least during the first year.
In the above-mentioned study, we observed that glomer-
ular enlargement was impaired in patients displaying CAN in
the protocol biopsy. We interpreted that glomerular adapta-
tion only occurs in renal allografts without chronic lesions. In
the present study, comparing 4-month and 1-year protocol
biopsies, we observed again that glomerular enlargement did
not occur in patients in whom chronic damage progressed
between the 4-month and 1-year protocol biopsy. This result
reinforces the notion that a preserved renal structure is a
necessary condition for glomerular volume adaptation.
Moreover, in patients without glomerular enlargement and
progression of chronic lesions, the severity of acute lesions
was increased in the 4-month and 1-year protocol biopsies.
This observation suggests that persistent inflammation is not
only associated with the progression of CAN16 but also with
an impaired glomerular adaptation after transplantation.
In the present study, we also described that patients with
small glomeruli in the first protocol biopsy showed a higher
glomerular enlargement. This result is in agreement with the
previous observation that smaller glomeruli in the donor
biopsy are associated with higher glomerular enlargement
evaluated in a 4-month protocol biopsy.15 Taken together,
these data suggest that glomerular volume at any time of
follow-up could partly determine the capacity for further
glomerular adaptation. Accordingly, the best suited design for
the characterization of glomerular adaptation after trans-
plantation is the study of serial biopsies.
We have previously shown that glomerular enlargement is
a necessary condition to achieve a better renal function after
transplantation.15 However, we have shown that in protocol
biopsies performed at 4 months, a large glomerular volume is
associated with a poor outcome in cases with poor renal
function but not in cases with a better renal function. These
data suggest that patients with large glomeruli and poor renal
function were unable to properly adapt to recipient metabolic
demand. On the contrary, large glomerular volume with
adequate renal function is associated with a better graft
Table 3 | Clinical parameters at the time of protocol biopsies
Variable
4-month
biopsy
1-year
biopsy P
Serum creatinine (mmol/l) 137740 137735 NS
Creatinine clearance (ml/min) 54715 54714 NS
Proteinuria (g/day) 0.3170.24 0.3570.47 NS
Mean arterial blood pressure (mm Hg) 101713 103711 NS
NS, not significant.
0
0.5
1
1.5
2
0
0.5
1
1.5
2
2.5
3
0
0.5
1
1.5
2
0
0.5
1
1.5
2
2.5
3
Vg1 Vg < 1
Early biopsy Late biopsy Early biopsy Late biopsy
*
*
v
t
i
g
cv
ct
ci
cg
*
*
*
Figure 2 | Evolution of acute and chronic lesions between the
4-month and 1-year biopsy in patients classified according to
glomerular enlargement (dVg, 106 lm3). *Po0.05.
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Figure 3 | Evolution of glomerulosclerosis between the 4-month
and 1-year biopsy in patients classified according to glomerular
enlargement (dVg,  106 lm3). *Po0.05.
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survival probably representing a proper adaptation to
recipient metabolic demand.17 In diagnostic biopsies per-
formed after the third year, it has been shown that there is an
association between large glomeruli and glomerulosclerosis.
This observation has been interpreted as an adaptation
mechanism related with hyperfiltration-mediated damage.14
In the present study, we observed that percentage of
glomerulosclerosis significantly progressed in patients with-
out glomerular enlargement but did not in patients with
glomerular enlargement. Thus, our data do not support that
glomerulosclerosis occurring during the first year after
transplantation is necessarily related with hyperfiltration-
mediated damage since in this case glomerular enlargement
should precede glomerulosclerosis. On the contrary, we
observed that glomerulosclerosis occurred in patients with
small glomeruli that showed persistent inflammation in both
biopsies. Taken together, our data suggest that persistent
inflammation not only favors the progression of tubulo-
interstitial damage but also is associated with impaired
glomerular enlargement and increased progression of glo-
merulosclerosis. We may speculate that the primary targets
for subclinical rejection are peritubular capillaries, tubules,
and interstitium,18 leading to tubular atrophy and conse-
quently to glomerulosclerosis. Thus, we suggest that during
the first year after transplantation, glomerulosclerosis is
probably not related with hyperfiltration-mediated damage
but with tubulo-interstitial inflammation. Nevertheless, our
data do not deny that after the first year, once subclinical
rejection has vanished in the majority of patients, glomer-
ulosclerosis may mainly represent hyperfiltration-mediated
damage as it has been suggested by Bhathena.14,19 Since
subclinical rejection and the presence of CAN in protocol
biopsies are associated with poor outcome,20–22 and both
lesions are associated with impaired glomerular volume
adaptation, our data once more support that glomerular
adaptation may be a necessary condition for prolonged graft
survival.
In summary, in the present study we observed that
impaired glomerular adaptation after transplantation is
associated with the presence of subclinical rejection as well
as with the progression of glomerulosclerosis and CAN.
MATERIALS AND METHODS
Patients
On June 1988, a prospective program of protocol biopsies in
deceased renal transplants was started at our center. A first protocol
renal allograft biopsy was performed at approximately 4 months in
patients who gave their informed consent and fulfilled the following
criteria: serum creatinine o300 mmol/l, proteinuria o1 g/day, and
stable renal function defined as a variability of serum creatinine of
o15% during 1 month before and after biopsy.23 A second protocol
biopsy was performed at 1 year regardless of renal function and
proteinuria until 1999.24 The Ethics Committee of our center
approved the study protocol. For the present study, we reviewed our
biopsy files to select patients with a serial 4-month and 1-year
protocol biopsy with an adequate sample according to 1997 Banff
criteria.25 Only biopsies containing at least seven glomerular
sections with undisrupted Bowman’s capsule in silver methenamine
stained slides were considered.
Biopsies
Biopsies were performed under ultrasound guidance with a 16-
gauge spring-loaded needle and processed for light microscopy.
Tissue was embedded in paraffin and stained with hematoxylin and
eosin, periodic acid-Schiff, Masson’s trichrome, and silver methen-
amine. Renal lesions were blindly graded and diagnosed according
to the 1997 Banff schema. Acute and chronic index scores were
calculated as the addition of individual scores in each renal
compartment. Subclinical rejection was defined as i-score X1 and
t-score X1. CAN was defined as ci-score X1 and ct-score X1.
Biopsies were not available to clinicians and accordingly were not
employed to take any clinical decision.
Morphometry
Silver methenamine stained sections were employed for histomor-
phometric analysis. Vg was estimated by a point counting method in
all the available glomeruli with undisrupted Bowman’s capsule in
one section. For this purpose, a grid of 560 points was displayed on
a television screen and the distance between grid points was
calibrated with a micrometer ruler. Glomerulus was defined as the
area inside the minimal convex polygon described by the outer
capillary loops of the tuft. The total number of points hitting the
glomerular tuft was counted at  200 magnification. Vg was
estimated from the mean glomerular area (A) according to the
Weibel and Gomez formula as:26
Vg ¼ A3=2  b=d ð1Þ
where b is 1.38, the shape coefficient of the sphere and d is 1.01, the
size distribution of glomeruli assuming a 10% coefficient of
variation of the caliper diameter.
The difference between Vg in the 1-year and 4-month biopsy
(dVg) was used to evaluate glomerular volume adaptation.
In order to evaluate glomerular shrinkage, the mean corpuscular
volume defined as the area inside the Bowman’s capsule was also
determined. The proportion of mean tuft volume to mean corpuscle
volume (tuft/corpuscle) was calculated.
Clinical variables
The following variables were evaluated in each patient at the time of
surgery: age and gender of the donor and the recipient, height and
weight of the recipient, presence of hepatitis C virus antibodies,
etiology of end stage renal disease, last panel reactive antibodies,
number of human leukocyte antigen mismatches, and cold ischemia
time. After surgery, the presence of delayed graft function and acute
rejection were evaluated. At the time of biopsy, serum creatinine,
proteinuria, and blood pressure were recorded. Exposure to
cyclosporine or tacrolimus was evaluated from the mean levels at
days 7, 14, 30, 60, 90, and the day of the protocol biopsy.
Body surface area was calculated according to Mosteller’s
formula27 and body mass index was calculated as body weight
divided by squared height. Creatinine clearance at the time of biopsy
was estimated according to Cockcroft and Gault formula.28
Statistics
Results are expressed as the mean7s.d. Comparison between paired
data was performed by the Wilcoxon T-test for ordinal variables or
not normally distributed continuous variables and by the paired
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Student’s t-test for continuous normally distributed variables.
Similarly, comparisons between unpaired data were carried out by
means of the Mann Whitney U-test or the Student’s t-test.
Simple regression analysis and stepwise multiple regression
analysis were employed to study the relationship between quanti-
tative variables. All P-values were two-tailed and a P-value o0.05
was considered significant.
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